Triferic (Rockwell Medical, Inc)


Welcome to the PulseAid listing for the Triferic drug offered from Rockwell Medical, Inc. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Rockwell Medical, Inc
NON-PROPRIETARY NAME: Ferric Pyrophosphate Citrate
SUBSTANCE NAME: FERRIC PYROPHOSPHATE CITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: HEMODIALYSIS; PARENTERAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-09-04
END MARKETING DATE: 0000-00-00


Triferic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTriferic from Rockwell Medical, Inc
LABELER NAME: Rockwell Medical, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 272(mg/50mL)
START MARKETING DATE: 2015-09-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57278-316_5b5dcf9d-071d-6aa4-e053-2991aa0afa32
PRODUCT NDC: 57278-316
APPLICATION NUMBER: NDA206317

Other FERRIC PYROPHOSPHATE CITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rockwell Medical, IncTriferic
Ropack Inc.Triferic